retatrutide triple agonist glp-1 gip glucagon phase 2 nejm 2023 Targeting GLP-1, & GCG in Obesity and Type Diabetes Research Retatrutide, a TRIPLE agonist (GLP1,
Pay in 4 interest-free payments of $6.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13



























